A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-1696
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors

Science Translational Medicine
Medicine
2017English

Carcinoembryonic Antigen (CEA) “Fingerprints”

British Journal of Cancer
Cancer ResearchOncology
1973English

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Cd20-TCB (Rg6026), a Novel “2:1” Format T-Cell-Engaging Bispecific Antibody, Induces Complete Remissions in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Evaluation of Carcinoembryonic Antigen (CEA) Test in AMHTS.

Japanese journal of AMHTS
1984English

Effect of Ricin or Ricin A-Chain Encapsulated in Anti-Carcinoembryonic Antigen (CEA) Antibody-Bearing Liposomes on CEA-producing Tumor Cells.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1987English

Prospects to Improve Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors

Immunotherapy
OncologyAllergyImmunology
2016English

Radiocurability by Targeting Tumor Necrosis Factor-Α Using a Bispecific Antibody in Carcinoembryonic Antigen Transgenic Mice

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2007English

A Novel GUCY2C-CD3 T Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers

Clinical Cancer Research
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy